Nisa Investment Advisors
MLYS icon

Nisa Investment Advisors’s Mineralys Therapeutics MLYS Stock Holding History

Nisa Investment Advisors’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58K Sell
2,151
-208
-9% -$5.71K ﹤0.01% 1797
2026
Q1 		$63.9K Buy
2,359
+410
+21% +$12K ﹤0.01% 1579
2025
Q4 		$70.7K Sell
1,949
-116
-6% -$4.65K ﹤0.01% 1535
2025
Q3 		$78.3K Hold
2,065
– – ﹤0.01% 1505
2025
Q2 		$27.9K Buy
2,065
+458
+29% +$6.64K ﹤0.01% 1786
2025
Q1 		$25.5K Buy
1,607
+1,504
+1,460% +$17.3K ﹤0.01% 1787
2024
Q4 		$1.27K Buy
103
+98
+1,960% +$1.28K ﹤0.01% 2618
2024
Q3 		$61 Sell
5
-61
-92% -$738 ﹤0.01% 2927
2024
Q2 		$772 Buy
66
+62
+1,550% +$781 ﹤0.01% 2579
2024
Q1 		$52 Buy
+4
New +$49 ﹤0.01% 2744

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $229M AUM 100.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Nisa Investment Advisors's MLYS Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Mineralys Therapeutics (MLYS) stake by 8.8% in Q2 2026, selling an estimated $5.71K and leaving 2,151 shares worth $58K. The position accounts for ﹤0.01% of the portfolio, ranked #1797.

Nisa Investment Advisors first reported a position in MLYS in Q1 2024 and has held it in 10 quarters since. The position peaked at $78.3K in Q3 2025. 62 funds tracked by Wall St. Rank hold MLYS as of Q2 2026.

  • Nisa Investment Advisors held 2,151 shares of Mineralys Therapeutics worth $58K as of Q2 2026.
  • Nisa Investment Advisors sold 208 Mineralys Therapeutics shares in Q2 2026, an estimated $5.71K.
  • Mineralys Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1797 holding.
  • Nisa Investment Advisors first reported a position in Mineralys Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Nisa Investment Advisors's Mineralys Therapeutics position peaked at $78.3K in Q3 2025.
  • 62 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.